CASE 8 (includes some pharm) Flashcards
what is osteoporosis?
a disease characterised by low bone mass (decreased bone mineral density BMD) and micro-architectual degeneration of bone tissue, leading to enhanced bone fragility and an increase in fracture risk
according to WHO, in osteoporosis the BMD is what below a normal healthy age-matched control?
BMD < 2.5 standard deviations a below a normal healthy age-matched control
what is T score?
patient’s BMD compared to young healthy control
what is Z score?
patient’s BMD compared to age-matched control
what is osteopenia?
defined as between 2.5 and 1 standard deviation below normal heathy control — can go on to develop osteoporosis
osteoporosis affects who?
- affects 1/3 of all UK women
- affects 1/12 of all UK men
what is the cost of osteoporosis to the NHS each year?
over £3 billion a year
name key differences between bone in an 18 year old vs. an 80 year old
18 year old — epiphyseal plate still open, trabeculae, relatively thick cortices of bone
what is the effect of menopause on osteoclasts?
increases the number of osteoclasts
what is the effect of menopause on osteoblasts?
decreases the number of osteoblasts
what are the falling oestrogen levels in menopause associated with? effect of osteoporosis?
increased osteoclasts associated with falling oestrogen levels. however bone secretions from women with osteoporosis show problems with osteoblasts therefore fewer esteoclasts
why is there a deficit in BMD?
- osteoblasts simply no longer “catch up” with the activity of osteoclasts — lower BMD
- menopause, with relatively sudden increase in osteoclast activity accelerates this process
what are the actions of oestrogen on osteoblasts?
- increased alkaline phosphatase expression
- increased collagen type 1 synthesis
- stimulates growth factors synthesis (IGF1, TGF-B, BMPs) — all important for controlling cell division and differentiation
- regulates osteoblast proliferation
- stimulates expression of VDR, marker for osteoblast maturation
what are the actions of oestrogen on osteoclasts?
- increases apoptosis of osteoclasts
- suppresses osteoclast differentiation
- act on osteoclasts via osteoblasts (IL6 or RANK/RANKL, osteoprotegerin)
where are RANK receptors located?
on the surface membrane of osteoclast progenitor cells
what is RANKL?
rank ligand that binds to RANK receptor in osteoclast activation
what secretes RANKL?
osteoblasts
what is the effect of RANKL binding to the RANK receptor?
initiates intracellular signalling and gene expression cascade that results in differentiation and maturation of the precursor cells into osteoclasts
what does osteoprotegerin do?
OPG protects the skeleton from excessive bone resorption by binding to RANKL and preventing it from binding to RANK receptor
what promotes the synthesis of OPG (osteoprotegerin)
oestrogen
what is the overexprexssion of RANKL linked to?
osteoporosis
what bone markers are used for osteoblasts and osteoclasts?
- osteoblasts = alkaline phosphatase
- osteoclasts = collagen breakdown products (teleopeptides)
what is osteoporosis a disease of?
bone remodelling
how long does 1 bone remodelling cycle take?
around 9 months